CAR-T: What’s next? Part 2
In my previous blog post, I suggested that the market size for gene-modified T-cell therapies would be roughly $9 Bn in 10 years, with a...
CAR-T: What’s next? Part 1
Over the last two months, several news events have brought CAR-T cells to widespread public attention, the most prominent of which is the...
